# Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)

> **NCT05009927** · PHASE2 · RECRUITING · sponsor: **Centre Leon Berard** · enrollment: 50 (estimated)

## Conditions studied

- Metastatic Gastrointestinal Stromal Tumor (GIST)
- C-KIT Mutation
- Advanced Gastrointestinal Stromal Tumor (GIST)

## Interventions

- **DRUG:** Imatinib tablets

## Key facts

- **NCT ID:** NCT05009927
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-03
- **Primary completion:** 2025-01
- **Final completion:** 2027-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05009927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05009927, "Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05009927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*